首页> 美国卫生研究院文献>International Journal of Medical Sciences >In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia
【2h】

In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia

机译:Colistin与替加环素联用对从呼吸机相关性肺炎患者中分离出的耐碳青霉烯类鲍曼不动杆菌的活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: This study investigated the minimum inhibitory concentration (MIC) values and in vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia (VAP) using the E-test method.>Methods: A total of 40 A. baumannii strains, identified using the Phoenix Automated Microbiology System (Becton, Dickinson and Co., Franklin Lakes, NJ, USA) by conventional methods, were included in this study. Pulsed-field gel electrophoresis was performed to examine the clonal relationships between isolates. The carbapenem resistance of the strains to colistin and tigecycline was assessed using the E-test method (Liofilchem, Roseto Degli Abruzzi, Italy). The in vitro activity of colistin in combination with tigecycline was evaluated using the fractional inhibitor concentration (FIC) index.>Results: While only 1 of 40 A. baumannii strains was determined to be colistin resistant, 6 were tigecycline resistant. The MIC50, MIC90, and MIC intervals of the A. baumannii strains were 0.19, 1.5, and 0.064‒4 μg/ml for colistin and 1, 8, and 0.094‒256 μg/ml for tigecycline, respectively. No synergistic effect was observed using the FIC index; 8 strains exhibited an indifferent effect and 32 exhibited an antagonist effect. Three of the six strains that were resistant to tigecycline were indifferent; the remaining three were antagonistic. The colistin-resistant strain also exhibited an antagonist effect.>Conclusion: In contrast to their synergistic effect against carbapenem-resistant A. baumannii isolates, colistin and tigecycline were highly antagonistic to carbapenem-resistant A. baumannii strains isolated from patients with VAP when the drugs were administered together. Therefore, alternative treatment options should be used during the treatment of VAP attributed to A. baumannii.
机译:>目的:本研究调查了大黄素与替加环素联合使用对从呼吸机相关性肺炎(VAP)患者中分离出的耐碳青霉烯类鲍曼不动杆菌的最低抑菌浓度(MIC)值和体外活性。电子测试方法。>方法:使用常规方法,通过Phoenix自动微生物系统(Becton,Dickinson和Co.,Franklin Lakes,NJ,美国)鉴定了总共40株鲍曼不动杆菌。包括在这项研究中。进行脉冲场凝胶电泳以检查分离株之间的克隆关系。使用E-test方法(Liofilchem,Roseto Degli Abruzzi,意大利)评估菌株对大肠菌素和替加环素的碳青霉烯抗性。使用分数抑制剂浓度(FIC)指数评估大肠菌素与替加环素的体外活性。>结果:虽然在40例鲍曼不动杆菌中仅1株被鉴定为对大肠菌素具有抗性,但6个是替加环素耐。鲍曼不动杆菌菌株的MIC50,MIC90和MIC区间对于大肠菌素分别为0.19、1.5和0.064±4μg/ ml,对于替加环素分别为1、8和0.094±256μg/ ml。使用FIC指数未观察到协同效应。 8个菌株表现出无差异的作用,而32个表现出拮抗作用。在对替加环素具有抗性的6个菌株中,有3个无差异。其余三个是对立的。大肠菌素耐药菌株也表现出拮抗作用。>结论:与大肠埃希菌耐药的鲍曼不动杆菌分离株相比,大肠粘菌素和替加环素与耐碳青霉烯鲍曼不动杆菌具有强烈的拮抗作用。当同时使用药物时,来自患有VAP的患者。因此,在归因于鲍曼不动杆菌的VAP的治疗期间应使用替代治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号